arbekacin has been researched along with Necrosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morikawa, K; Nonaka, M; Torii, I; Yoshikawa, Y | 1 |
| Hashimoto, Y; Inui, K; Kokuryo, T; Nakamura, T; Okuda, M | 1 |
2 other study(ies) available for arbekacin and Necrosis
| Article | Year |
|---|---|
Effect of arbekacin on a methicillin-resistant Staphylococcus aureus-induced biofilm in a rat model.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Biofilms; Dibekacin; Disease Models, Animal; Granuloma; Humans; Male; Methicillin Resistance; Microscopy, Electron, Scanning; Necrosis; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2004 |
Effects of arbekacin and vancomycin on release of lactate dehydrogenase and fragmentation of DNA in LLC-PK1 kidney epithelial cells.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Cisplatin; Dibekacin; DNA Damage; DNA Fragmentation; Kidney Tubules; L-Lactate Dehydrogenase; LLC-PK1 Cells; Necrosis; Swine; Vancomycin | 1999 |